Mannose-binding lectin deficiency
Última actualización 19 Sept 2024
Cumple con las directrices editoriales
- DescargarDescargar
- Compartir
- Language
- Discusión
- Ask Patient
- Versión en audio
- Agregar a fuentes preferidas en Google
Mannose-binding lectin deficiency is a condition that affects the immune system. People with this condition have low levels (deficiency) of an immune system protein called mannose-binding lectin in their blood. Whether this deficiency makes affected individuals prone to recurrent infections is not clear.
Selecciones de videos para Condiciones genéticasBiblioteca de videos
Descripción
Mannose-binding lectin deficiency is a condition that affects the immune system. People with this condition have low levels (deficiency) of an immune system protein called mannose-binding lectin in their blood. Whether this deficiency makes affected individuals prone to recurrent infections is not clear.
People with mannose-binding lectin deficiency can develop infections of the upper respiratory tract and other body systems. Individuals with this condition may also contract more serious infections such as pneumonia and meningitis. Depending on the type of infection, the symptoms caused by the infections vary in frequency and severity.
Infants and young children with mannose-binding lectin deficiency seem to be more susceptible to infections than affected adults, but adults can also develop recurrent infections. In addition, affected individuals undergoing chemotherapy or taking drugs that suppress the immune system are especially prone to infections.
Patrones de herencia
The source lists the following possible inheritance patterns: Pattern unknown. More than one pattern can apply in different cases.
Related genes
Otros nombres
Mannose-binding lectin protein deficiency
Mannose-binding protein deficiency
MBL deficiency
MBL2 deficiency
MBP deficiency
Related patient information and medicines

Patient information leaflet
Cistitis recurrente en mujeres
Dr Sarah Jarvis MBE Some women have recurring bouts of cystitis, sometimes defined as two proven infecciones within six months, or three infections in a year..

Patient information leaflet
Colangitis biliar primaria
Primary biliary cholangitis (PBC) es un condition that slowly damages the bile ducts in your liver, leading to liver damage and, sometimes, liver scarring (cirrhosis). What is primary biliary cholangitis. Primary biliary cholangitis (PBC) es un auto-immune condition in which your immune system gradually destroys the tiny tubes (bile ducts) which.

Patient information leaflet
Malabsorción gastrointestinal
Gastrointestinal malabsorption syndrome means a failure to fully absorb digested foods from the gut (bowel) into your body. There are many different causes. Prolonged intestinal malabsorption may cause problems because of a lack of carbohydrates, proteins, fats, minerals and vitamins that are essential to keep you healthy. The treatment will.

Patient information leaflet
¿Puedo tomar Colesevelam y Naproxeno juntos?
Taking colesevelam at the same time as naproxen can significantly reduce the amount of naproxen your body absorbs. This means the naproxen may not work as well to relieve your pain or inflammation. Why this happens Colesevelam is a 'bile acid sequestrant' designed to bind to substances in your digestive system. It can accidentally trap naproxen.

Patient information leaflet
¿Puedo tomar ácido fólico y vitamina B12 juntos?
Tomar ácido fólico on its own can hide (mask) a vitamin B12 deficiency. Using other medicines Taking multiple medicines. Our Medicines Interaction Checker helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take juntos. Simply search for your medicines to see potential interactions and what to do.

Patient information leaflet
¿Puedo tomar Omeprazol y Vitamina B12 juntos?
Tomar omeprazol for a long time can make it harder for your body to absorb vitamina B12 from the food you eat. Over several years, this could lead to a vitamin B12 deficiency. Why this happens Vitamin B12 is naturally bound to proteins in food. To release the vitamin so your body can use it, you need stomach acid. Omeprazole works by reducing the.
Lecturas adicionales y referencias
- Mannose-binding lectin deficiency; MedlinePlus, National Library of Medicine.
- Arora M, Munoz E, Tenner AJ. Identification of a site on mannan-binding lectin critical for enhancement of phagocytosis. J Biol Chem. 2001 Nov 16;276(46):43087-94. doi: 10.1074/jbc.M105455200. Epub 2001 Aug 30.
- Bouwman LH, Roep BO, Roos A. Mannose-binding lectin: clinical implications for infection, transplantation, and autoimmunity. Hum Immunol. 2006 Apr-May;67(4-5):247-56. doi: 10.1016/j.humimm.2006.02.030. Epub 2006 Apr 17.
- Degn SE, Jensenius JC, Thiel S. Disease-causing mutations in genes of the complement system. Am J Hum Genet. 2011 Jun 10;88(6):689-705. doi: 10.1016/j.ajhg.2011.05.011.
- Martin P, Lerner A, Johnson L, Lerner DL, Haraguchi S, Good RA, Day NK. Inherited mannose-binding lectin deficiency as evidenced by genetic and immunologic analyses: association with severe recurrent infections. Ann Allergy Asthma Immunol. 2003 Oct;91(4):386-92. doi: 10.1016/S1081-1206(10)61686-9.
- Ram S, Lewis LA, Rice PA. Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev. 2010 Oct;23(4):740-80. doi: 10.1128/CMR.00048-09.
- Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol. 2003 Nov;40(7):423-9. doi: 10.1016/s0161-5890(03)00155-x.
- Weis WI, Drickamer K, Hendrickson WA. Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature. 1992 Nov 12;360(6400):127-34. doi: 10.1038/360127a0.
Comparte tus pensamientos o experiencias con otros en nuestro comunidades de pacientes.
Suscríbete al boletín de Patient
Tu dosis semanal de consejos de salud claros y confiables, escritos para ayudarte a sentirte informado, seguro y en control.
Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.

